Exelixis (EXEL) EPS (Weighted Average and Diluted) (2016 - 2026)
Exelixis (EXEL) has 15 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.88 in Q1 2026.
- For Q1 2026, EPS (Weighted Average and Diluted) rose 83.33% year-over-year to $0.88; the TTM value through Jan 2026 reached $2.78, up 57.06%, while the annual FY2026 figure was $2.78, 57.95% up from the prior year.
- EPS (Weighted Average and Diluted) reached $0.88 in Q1 2026 per EXEL's latest filing, up from $0.7 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.88 in Q1 2026 and bottomed at -$0.09 in Q4 2022.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.36, with a median of $0.26 recorded in 2023.
- Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 139.08% in 2022, then soared 12360.21% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.09 in 2022, then soared by 411.11% to $0.28 in 2023, then skyrocketed by 42.86% to $0.4 in 2024, then soared by 75.0% to $0.7 in 2025, then increased by 25.71% to $0.88 in 2026.
- Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.88 in Q1 2026, $0.7 in Q4 2025, and $0.65 in Q3 2025.